Login to Your Account



$98M for Phase III Allergy Vaccines Studies

Circassia Lands 3rd Largest Biotech Funding in Europe

By Nuala Moran


Wednesday, April 20, 2011
LONDON – Circassia Ltd. claimed the third largest funding round by a European biotech in the past 15 years, raising $98 million in a fourth round.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription